1h Free Analyst Time
The U.S. e-prescribing market by revenue is expected to grow at a CAGR of 20.68% during the period 2022–2027.Speak directly to the analyst to clarify any post sales queries you may have.
E-prescribing uses healthcare technologies to improve prescription accuracy, enhance patient safety, and ensure cost savings. Also, e-prescribing allows real-time, secure, and bi-directional electronic connectivity between prescribers and pharmacies. Telehealth in the country is also growing rapidly as healthcare providers are implementing more sophisticated health IT infrastructures. The rise in third-party vendors offering add-on telehealth services and advancing practice management tools are allowing to integrate more consults into providers’ workflow, and these advancements will boost the e-prescribing services in the market.
SNIPPETS
- Rising concerns over medication and prescription errors resulting in drug overdose deaths are driving the demand for electronic prescribing, accelerating the growth of the US e-prescribing market.
- High adoption of EHRs and the launch of new government initiatives and incentive policies are creating opportunities for emerging players, thereby driving the growth of the market.
The report considers the present scenario of the U.S. e-prescribing market and its market dynamics for the period 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply side of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.
U.S. E-PRESCRIBING MARKET SEGMENTATION
This research report includes a detailed segmentation by:
- Type
- Delivery Mode
- Modality
- Medication Type
- End-user
SEGMENTATION ANALYSIS
- In the e-prescribing market, electronic prescribing of medications has become one of the core functions of EHR that has been available for decades and is mainly used in acute care. Over the same period, other forms of HIT, including prescription monitoring programs and disease registries, began to be more widely deployed.
- The EPCS technology can enable healthcare providers to directly integrate opioid prescription information into EHRs, which can improve patient safety, help prevent diversion, fraud, and the ECPS systems can streamline clinician workflow and reduce patient burden.
Market Segmentation by Type
- Standard E-prescribing
- EPCS (Electronic prescribing of controlled substances)
Market Segmentation by Delivery Mode
- Web and Cloud-Based
- On-Premises and Desktop
Market Segmentation by Modality
- Integrated
- Standalone
Market Segmentation by Medication Type
- Cardiovascular
- Oncology
- Anti-Infectives
- Behavioural and Mental Health
- Pain Medication
- Others
Market Segmentation by End-User
- Healthcare facilities
- EHR, Telehealth & pharmacy software vendors
- Independent and Speciality Pharmacies
- Pharmacy benefit managers (PBM) and Payors
VENDOR ANALYSIS
- Several EHR vendors are integrating e-prescribing services into their EHR software to attract the attention of end-users utilizing the EHR services. These vendors are focusing on providing integrated e-prescribing services, contributing to the major share of the market.
- Players who have significantly contributed to the growth of the US e-prescribing market are Surescripts, DrFirst, Practice Fusion, and Insync Healthcare Solutions. However, the market is expected to experience high growth and competition due to the growing small- and mid-size players collaborating with the technology providers to promote their e-prescribing solutions.
Prominent Vendors
- Athenahealth
- Cerner Corporation
- DrFirst
- Henry Schein Inc.
- InSync Healthcare Solutions
- Practice Fusion Inc.
- Surescripts
Other Prominent Vendors
- AdvancedMD
- Aegis Healthcare
- Allscripts Healthcare
- Bizmatics
- Bravado Health
- CareCloud
- Change Healthcare
- Chetu
- Credible
- Daw Systems
- DoseSpot
- Dr. Chrono
- eClinicalWork
- eMDs
- Kareo
- MD Toolbox
- Medical Information Technology Inc
- NextGen Healthcare
- RXNT
- SISGAIN
- Streamline Healthcare Solutions
- TenEleven Group
- WebPT
KEY QUESTIONS ANSWERED:
1. How big is the U.S. e-prescribing market?
2. What are the factors driving the US e-prescribing market?
3. Who are the key players in the e-prescribing market in the US?
4. Who are the end-users in the e-prescribing market in the US?
5. Which segment has the highest share in the US e-prescribing market?
Table of Contents
1 Research Methodology2 Research Objectives3 Research Process6 Market at a Glance
4 Scope & Coverage
5 Report Assumptions & Caveats
7 Introduction
8 Market Opportunities & Trends
9 Market Growth Enablers
10 Market Growth Restraints
11 Market Landscape
12 Type
13 Delivery Mode
14 Modality
15 Medication Type
16 End-User
17 Competitive Landscape
18 Key Company Profiles
19 Other Prominent Vendors
20 Report Summary
21 Quantitative Summary
22 Appendix
LIST OF EXHIBITS
LIST OF TABLES
Companies Mentioned
- Athenahealth
- Cerner Corporation
- DrFirst
- Henry Schein Inc.
- InSync Healthcare Solutions
- Practice Fusion Inc.
- Surescripts
- AdvancedMD
- Aegis Healthcare
- Allscripts Healthcare
- Bizmatics
- Bravado Health
- CareCloud
- Change Healthcare
- Chetu
- Credible
- Daw Systems
- DoseSpot
- Dr. Chrono
- eClinicalWork
- eMDs
- Kareo
- MD Toolbox
- Medical Information Technology Inc
- NextGen Healthcare
- RXNT
- SISGAIN
- Streamline Healthcare Solutions
- TenEleven Group
- WebPT
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
